PMID: 7537333Apr 14, 1995Paper

Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors

Journal of Medicinal Chemistry
T R BurkeX Yan

Abstract

Inhibitors of specific src homology 2 (SH2) domain binding interactions could potentially afford new therapeutic approaches toward a variety of diseases, including several cancers. To date SH2 domain inhibitors have been confined to small phosphotyrosyl (pTyr)-containing peptides that appear to bind along the surface of SH2 domains with specific recognition features protruding into the protein. Among these protrusions is the pTyr residue itself, which is inserted into a well-formed binding pocket. In the present study monomeric pTyr mimetics were prepared having key aspects of their structure constrained to conformations of the bound pTyr residue observed in the previously reported X-ray structure of a pTyr-peptide bound to the Lck SH2 domain. The resulting constrained pTyr mimetics were examined for inhibitory potency in six SH2 domain constructs: Lck, Src, Grb2, and the C-terminal SH2 domains of PLC gamma (PLC gamma-C) and the p85 subunit of PI-3 kinase (p85-C), as well as the N-terminal SH2 domain of SH PTP2. Although inhibition constants were in the millimolar range, it was observed that capping pTyr as its N alpha-acetyl carboxamide [(L)-1] provided a roughly 2-3-fold increase in potency relative to free pTyr. Diastereomer...Continue Reading

Citations

Aug 1, 1997·Current Opinion in Biotechnology·T Kieber-EmmonsM I Greene
Sep 15, 2000·Bioorganic & Medicinal Chemistry Letters·J LeppänenT Järvinen
Aug 18, 1999·Bioorganic & Medicinal Chemistry Letters·G CaravattiP Furet
Mar 5, 2003·Bioorganic & Medicinal Chemistry·Frank J DekkerRob M J Liskamp
Oct 15, 2013·Chemical Reviews·Jacques RoudenJérôme Baudoux
Jan 13, 2009·Journal of the American Chemical Society·Sarvin MoghaddamMichael K Gilson
May 3, 2000·Journal of Hematotherapy & Stem Cell Research·S Sinha, S J Corey
Mar 1, 2006·International Journal of Peptide Research and Therapeutics·Terrence R Burke
Nov 4, 2010·The FEBS Journal·Denis PhichithBerangere Avalle
Nov 2, 1999·Journal of Molecular Biology·J M BradshawG Waksman
Jan 15, 2015·Chemical Communications : Chem Comm·Dorota Kowalczyk, Łukasz Albrecht
Aug 26, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Weiming XuYuping Zhang
Dec 17, 2009·Chemistry : a European Journal·Łukasz AlbrechtKarl Anker Jørgensen
Jun 18, 2003·Accounts of Chemical Research·Terrence R Burke, Kyeong Lee
Sep 20, 1996·Journal of Chromatography. B, Biomedical Applications·J A Boutin
Mar 12, 1999·Journal of Medicinal Chemistry·T R Lee, D S Lawrence
Oct 24, 2001·The Journal of Organic Chemistry·Dominique AlbouyGuita Etemad-Moghadam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.